AML1–ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemia

Friederike Schneider,Stefan K. Bohlander,S. Schneider,C Papadaki,P Kakadyia,Annika Dufour,Sridhar Vempati,M. Unterhalt,Michaela Feuring-Buske,C Buske,Jan Braess,Hannes Wandt,W. Hiddemann,Karsten Spiekermann

AML1–ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemia

2007

Friederike Schneider
Stefan K. Bohlander
S. Schneider
C Papadaki
P Kakadyia
Annika Dufour
Sridhar Vempati
M. Unterhalt
Michaela Feuring-Buske
C Buske
Jan Braess
Hannes Wandt
W. Hiddemann
Karsten Spiekermann

AML1–ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemia

Keywords:

Cancer research
Genetics
Myeloid leukemia
Biology
Immunology
aml1 eto
clinical evidence

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations